KLK3 and prostate cancer: Nonmetastatic castration-resistant prostate cancer (nmCRPC) is an intermediate stage of prostate cancer (PC), which is characterized by persistently elevated prostate-specific antigen (PSA) but without detectable radiological evidence showing distant metastasis even after androgen deprivation therapy (ADT) (1).